期刊文献+

重组人乳铁蛋白小鼠喂养毒理学评价 被引量:5

Twenty-eight days feeding study on human lactoferrin expressed by cattle mammary bioreactor in mice
原文传递
导出
摘要 目的探讨牛乳腺生物反应器表达的人乳铁蛋白对小鼠亚急性毒性。方法断乳昆明小鼠48只,雌雄各半,随机分为2组,对照组给予AIN-93啮齿类实验动物纯合饲料,人乳铁蛋白组饲料用重组人乳铁蛋白替代AIN-93中的酪蛋白制成,进行小鼠28 d喂养试验,每周记录体重和进食量,实验结束时分析血液、取脏器称重并进行病理组织学检查。结果人乳铁蛋白组雄性小鼠终体重为(38.3±3.1)g,高于对照组的(34.9±4.3)g;人乳铁蛋白组雌性小鼠终体重为(31.2±2.4)g,对照组终体重为(31.2±1.9)g,2组差异无统计学意义;与对照组比较,人乳铁蛋白组小鼠食物利用率、血常规、血生化、脏器重量、脏体比和病理组织学检查结果未见明显改变。结论牛乳腺生物反应器表达的重组人乳铁蛋白对小鼠未见亚急性毒性作用。 Objective To investigate sub-acute toxicity of recombinant human lactoferrin(rhLf) from cattle mammary bioreactor in mice. Methods Groups of 12 male and 12 female weaning Kuming mice were fed with AIN-93 purified diets for laboratory rodents( control group) or rhLf modified diets( treated group) ,in which 20 g casein/100 g AIN-93 diet was substituted for 20 g rhLf/100 g diet,for a consecutive 28-day period. Body weight and food intake were recorded weekly. At the end of the study, blood was collected for routine and biochemical blood examination and organs were dissected and weighted; histopathological examination was accomplished simutaneously. Results The final mean body weight of rhLf-treated male mice was 38.3 g ±3.1 g,higher than that of the control (34. 9 g ±4. 3 g) significantly,but there was no significant difference between two female groups ( 31.2 g ± 2.4 g in the treated and 31.2 g ± 1.9 g in the control). Food utilization rate, routine blood examination and biochemistry, absolute and relative weight of organs, and histopathology of organs of treated male and female mice were similar to those of the controls. Conclusion No evidence of sub toxicity was observed in the mice administered with recombinant human lactoferrin for 28 days.
出处 《中国公共卫生》 CAS CSCD 北大核心 2013年第2期230-232,共3页 Chinese Journal of Public Health
基金 国家863计划项目(2007AA100506) 转基因生物新品种培育科技重大专项(2008ZX08011-005)
关键词 人乳铁蛋白 转基因 牛乳腺生物反应器 28 d喂养试验 human lactoferrin transgene cattle mammary bioreactor 28-days feeding study
  • 相关文献

参考文献12

  • 1Makiko Y,Masaya I,Yoshihiko I. A 12-month feeding study of reproduction/development in rats fed meat/milk powder supplemented diets derived from the progeny of cloned cattle produced by somatic cell nuclear transfer[J].Journal of Reproduction and Development,2008,(05):321-334.
  • 2Center for Veterinary Medicine,US Food and Drug Administration. Animal cloning:a risk assessment[EB/OL].http://www.fda.gov/AnimalVeterinary/SafetyHealth/AnimalCloning/ucm055489.htm,2011.
  • 3European Food Safety Authority. Update on the state of play of animal cloning[J].EFSA Journal,2010,(09):1784.
  • 4朱小甫,渠敬峰,吴旭锦,樊松涛,马秋明,高睿.转基因动物乳腺生物反应器研究进展[J].畜牧兽医杂志,2007,26(3):50-52. 被引量:8
  • 5张艳杰.乳铁蛋白的功能特性及其在婴儿配方奶粉中的应用[J].中国乳品工业,2005,33(2):33-36. 被引量:24
  • 6Atsushi I,Syoko U,Hirohisa S. Human trial of liposomal lactoferrin supplementation for periodontal disease[J].Biological and Pharmaceutical Bulletin,2010,(10):1758-1762.
  • 7Jochen W,Andreas V. Antimicrobial peptides:the ancient aim of the human immune system[J].Virulence,2010,(05):440-464.
  • 8Haversen L,Kondori N,Baltzer L. Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial α-helix of human lactoferrin[J].Antimicrobial Agents and Chemotherapy,2010,(01):418-425.
  • 9Paolo M,Matteo R,Silvia C. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates[J].Journal of the American Medical Association,2009,(13):1421-1428.
  • 10Shinichi S,Yoshiharu T,Koko M. Lactoferrin promotes hyaluronan synthesis in human dermal fibroblasts[J].Biotechnology Letters,2011.33-39.

二级参考文献30

共引文献36

同被引文献33

  • 1李芳,徐海滨.转Bt基因玉米中外源蛋白的安全性评价策略及挑战[J].国外医学(卫生学分册),2005,32(2):96-99. 被引量:6
  • 2陈红兵,高金燕.食物过敏反应及其机制[J].营养学报,2007,29(2):105-109. 被引量:43
  • 3施向东,卢洁.转基因食品安全与发展[J].中国公共卫生,2007,23(8):1014-1016. 被引量:4
  • 4邢立国 王捷 蔡磊明.转基因植物致敏性评价方法研究现状.卫生毒理学杂志,2003,17(1):54-56.
  • 5Sicherer SH,Sampson HA. Food allergy [J]. Allergy Clin Immu-nol,2010,125 :116 -125.
  • 6Ladies GS,Knippels LM,Penninks AH,et al. Review of animalmodels designed to predict the potential allergenicity of novelproteins in genetically modified crops [ J ]. Regul Toxicol Pharma-col,2010,56(2) :212-224.
  • 7Ward P P, Paz E, Conneely O M. Muhifunctional roles of lactoferrin : a critical overview [ J]. CMLS ,2005,62 (22) :2540.
  • 8Bethell D R, HUANG J. Recombinant human lactoferrin treatment for global health issues: iron deficiency and acute diarrhea[ J]. Biometals, 2004,17 ( 3 ) :337-342.
  • 9HU W, ZHAO J, WANG J, et al. Transgenic milk containing recombinant human lactoferrin modulates the intestinal flora in piglets [ J ]. Biochemistry and Cell Biology ,2012,90 ( 3 ) :485.
  • 10ZHOU C,SUN N, WANG J, et al. Allergenicity assessment of a genetically modified protein-recombinant human lactoferrin [ J]. J Aller Ther S ,2013 ( S3 ) :2.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部